Summary
- Study conducted on Black South African men with prostate cancer identified known risk alleles and variants associated with aggressive prostate cancer at presentation
- The study used whole genome sequencing data from 113 cases, filtering for African genetic ancestry and compared risk allele frequencies with previously reported data
- Polygenic risk scoring did not show significant associations with aggressive prostate cancer using African or multiethnic weights
- Exome-wide association studies found several top associated variants, including those in genes HCP5, MUC22, and RFX6
- Rare variant analyses identified genes such as H3C1, MBP, and MTG1 associated with prostate cancer risk, with SNP heritability explaining a significant portion of disease liability
Researchers in South Africa have identified genetic risk factors for prostate cancer in Black South African men. The study analyzed whole genome sequencing data from 113 Black South African men with prostate cancer. The research focused on known risk variants and previously associated variants from African genome-wide association studies.
The study found that certain genetic risk variants were more common in the South African population compared to African-ancestral controls. The researchers also looked at polygenic risk scores to assess the risk of aggressive prostate cancer in this population. They found that certain genetic variants were associated with an increased risk of aggressive prostate cancer.
Additionally, the study examined common risk variants associated with prostate cancer in Black South Africans. They identified several genetic variants in genes related to prostate cancer processes. The researchers also looked at the variance explained by genetic variants in prostate cancer risk.
Overall, the study provides valuable insights into the genetic factors contributing to prostate cancer in Black South African men. This research could help in developing personalized treatment approaches for prostate cancer based on an individual’s genetic risk profile.
Source link
Oncology, Urology